A research collaboration between Intermountain Medical Center and ARUP Laboratories recently led to the development of a new and simple…
Articles by Inês Martins, PhD
Statins, the cholesterol lowering drugs, may improve the beneficial effects of Rho-kinase inhibitors in pulmonary arterial hypertension (PAH), according to…
Inhibiting the molecular chaperone heat shock protein 90 (HSP90) may be a promising therapeutic approach in pulmonary arterial hypertension (PAH),…
Gene therapy may offer a promising therapeutic approach for pulmonary arterial hypertension (PAH), according to an animal study conducted by Japanese researchers.
INOpulse, a nitric oxide delivery device that is being developed by Bellerophon Therapeutics, was approved by health authorities in Belgium to…
The presence of atrial arrhythmias may help predict unfavorable prognosis in patients with pulmonary hypertension (PH), according to a study published…
Measuring right ventricular (RV) function in patients with pulmonary arterial hypertension (PAH) using echocardiography is useful to predict patients’ prognosis,…
Sensitivity to DNA damage may act as an early trigger of pulmonary arterial hypertension (PAH), according to researchers at the Universitaire de…
The European Medicines Agency (EMA), the European Union parallel to the U.S. Food and Drug Administration (FDA), advised that the…
Researchers at the Nagoya University Graduate School of Medicine in Japan demonstrated that the endothelin receptor antagonist bosentan can improve…
Researchers from Tufts Medical Center in Boston identified two new biomarkers that may help predict survival in patients with pulmonary arterial…
Researchers at Harvard School of Public Health in Boston recently revealed that pulmonary arterial stiffening may be an early event…